Search results
Author(s):
Arturo Evangelista
Added:
3 years ago
The International Registry of Acute Aortic Dissection (IRAD) was established in 1996, enrolling patients at large referral centres worldwide. It represents a unique opportunity to assess the current presentation, management and outcome of acute aortic syndrome (AAS). The IRAD is an observational registry with more than 1,500 patients enrolled at 21 tertiary centres in six countries. Collected…
View more
Author(s):
Marco Bergonti
Added:
11 months ago
EHRA 23 - Dr Marco Bergonti (Istituto Cardiocentro Ticino, CH) to discuss the key takeaways from the ANTWOORD II Trial.
In this study, 605 heart failure patients undergoing atrial fibrillation ablation were enrolled to receive an ANTWERP Score, which aimed to predict LVEF recovery. 70% of patients were categorised as 'responders', patients identified as those who could benefit the most from AF…
View more
Author(s):
Andrea Silvio Giordani
,
Anna Baritussio
,
Cristina Vicenzetto
,
et al
Added:
11 months ago
Author(s):
Luc Janssens
Added:
3 years ago
Chronic heart disease is the leading cause of death in both men and women in the US, and coronary artery disease (CAD) constitutes the number one cause among them. Acute ST-segment-elevation myocardial infarction (STEMI) usually occurs when a thrombus forms on a ruptured atheromateus plaque and occludes an epicardial coronary artery. Patient survival depends on several factors, the most important…
View more
Author(s):
Jean-Luc Vachiéry
Added:
3 years ago
Prostacyclins in PAH - Pathobiological Rationale
Endothelial dysfunction is the cornerstone event in the pathobiology of pulmonary arterial hypertension (PAH), a rapidly evolving clinical syndrome of dyspnoea and fatigue eventually leading to right ventricular failure and death.1 In the pulmonary vascular bed, endothelial cells are the major source of mediators modulating pulmonary vascular tone…
View more
Author(s):
Gerald V Naccarelli
,
Deborah L Wolbrette
,
Soraya Samii
,
et al
Added:
3 years ago
Currently available antiarrhythmic drugs for the treatment of atrial fibrillation are limited in their efficacy and have potential for adverse effects, including torsade de pointes. With the aging of the population, the incidence of atrial fibrillation will double in frequency over the next 15 years. Thus, more effective and safer antiarrhythmic drugs for the treatment of atrial fibrillation are…
View more
Author(s):
Frank Provenier
,
Steven Droogmans
Added:
3 years ago
Atrial fibrillation (AF) is defined as a supraventricular tachycardia with rapid uncoordinated atrial activation, beat-to-beat irregularity and frequently rapid ventricular rate.2 It is the most frequently observed sustained arrhythmia in clinical practice.3 An estimated 12 million individuals in the EU and 2.3–10 million in the US have AF, and these numbers are expected to increase as the age of…
View more
Author(s):
Philippe Amubuomombe Poli
,
Elkanah Omenge Orang’o
,
Ann Mwangi
,
et al
Added:
3 years ago
Pregnancy in women with cardiac disease is associated with life-threatening complications. Although there has been progress in the field, cardiac disease in pregnancy remains among the leading causes of maternal and neonatal mortality and morbidity.1–3 Many studies have shown correlations between pregnancy-related haemodynamic changes and cardiac events.4–7 However, few studies have investigated…
View more
Author(s):
Alvaro Alonso
,
Antonio P Arenas de Larriva
Added:
3 years ago
Atrial fibrillation (AF) is the most common clinically-significant arrhythmia in the world.1 It is estimated that, in the US alone, approximately 2.5 million people have AF, with the condition being 1.5 times more common in men than in women.2 Despite the decline in morbidity and mortality from cardiovascular diseases in general due to advances in prevention and treatment, AF has not followed a…
View more
Author(s):
Velislav N Batchvarov
Added:
3 years ago
The two most important, both medically and socially, cardiac arrhythmic problems of our time are sudden cardiac death due to ventricular fibrillation (VF) (mainly in the setting of coronary artery disease) and atrial fibrillation (AF). For both of them, the identification of electrocardiogram ( ECG) markers that can reliably predict the occurrence of the arrhythmia is generally an unresolved…
View more